NFKB1 and Alzheimer disease: These effects were potentially mediated through modulation of the NF-κB pathway.<h4>Conclusion</h4>By simultaneously mitigating skin barrier dysfunction, immune inflammation, and pruritus, SCSE and Sch B hold promise as therapeutic candidates capable of disrupting the self-perpetuating cycle of AD.